<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">19806191</article-id>
      <article-id pub-id-type="pmc">2751828</article-id>
      <article-id pub-id-type="publisher-id">09-PONE-RA-10393R1</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0007303</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Biochemistry/Chemical Biology of the Cell</subject>
          <subject>Biochemistry/Drug Discovery</subject>
          <subject>Immunology/Cellular Microbiology and Pathogenesis</subject>
          <subject>Microbiology/Microbial Growth and Development</subject>
          <subject>Microbiology/Parasitology</subject>
          <subject>Infectious Diseases/Protozoal Infections</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Inherited Glutathione Reductase Deficiency and <italic>Plasmodium falciparum</italic> Malaria&#x2014;A Case Study</article-title>
        <alt-title alt-title-type="running-head">GR Deficiency and Malaria</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Gallo</surname>
            <given-names>Valentina</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Schwarzer</surname>
            <given-names>Evelin</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rahlfs</surname>
            <given-names>Stefan</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schirmer</surname>
            <given-names>R. Heiner</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van Zwieten</surname>
            <given-names>Rob</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Roos</surname>
            <given-names>Dirk</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arese</surname>
            <given-names>Paolo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Becker</surname>
            <given-names>Katja</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <addr-line>Dipartimento di Genetica, Biologia e Biochimica, University of Turin, Turin, Italy</addr-line>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <addr-line>Interdisziplin&#xE4;res Forschungszentrum, Gie&#xDF;en University, Gie&#xDF;en, Germany</addr-line>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <addr-line>Biochemie-Zentrum Heidelberg, Heidelberg University, Heidelberg, Germany</addr-line>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <addr-line>Sanquin Research and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Carlow</surname>
            <given-names>Clotilde K. S.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">New England Biolabs, United States of America</aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email>katja.becker@ernaehrung.uni-giessen.de</email></corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: VG ES SR RHS PA KB. Performed the experiments: VG ES SR RvZ. Analyzed the data: VG ES SR RHS KB. Contributed reagents/materials/analysis tools: ES RHS RvZ DR PA KB. Wrote the paper: VG SR RHS DR PA KB.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>6</day>
        <month>10</month>
        <year>2009</year>
      </pub-date>
      <volume>4</volume>
      <issue>10</issue>
      <elocation-id>e7303</elocation-id>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>5</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>9</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Gallo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement>
      </permissions>
      <abstract>
        <p>In <italic>Plasmodium falciparum</italic>-infected red blood cells (RBCs), the flavoenzyme glutathione reductase (GR) regenerates reduced glutathione, which is essential for antioxidant defense. GR utilizes NADPH produced in the pentose phosphate shunt by glucose-6-phosphate dehydrogenase (G6PD). Thus, conditions affecting host G6PD or GR induce increased sensitivity to oxidants. Hereditary G6PD deficiency is frequent in malaria endemic areas and provides protection against severe malaria. Furthermore, GR deficiency resulting from insufficient saturation of the enzyme with its prosthetic group FAD is common. Based on these naturally occurring phenomena, GR of malaria parasites and their host cells represent attractive antimalarial drug targets. Recently we were given the opportunity to examine invasion, growth, and drug sensitivity of three <italic>P. falciparum</italic> strains (3D7, K1, and Palo Alto) in the RBCs from three homozygous individuals with total GR deficiency resulting from mutations in the apoprotein. Invasion or growth in the GR-deficient RBCs was not impaired for any of the parasite strains tested. Drug sensitivity to chloroquine, artemisinin, and methylene blue was comparable to parasites grown in GR-sufficient RBCs and sensitivity towards paraquat and sodium nitroprusside was only slightly enhanced. In contrast, membrane deposition of hemichromes as well as the opsonizing complement C3b fragments and phagocytosis were strongly increased in ring-infected RBCs of the GR-deficient individuals compared to ring-infected normal RBCs. Also, in one of the individuals, membrane-bound autologous IgGs were significantly enhanced. Thus, based on our <italic>in vitro</italic> data, GR deficiency and drug-induced GR inhibition may protect from malaria by inducing enhanced ring stage phagocytosis rather than by impairing parasite growth directly.</p>
      </abstract>
      <counts>
        <page-count count="9"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>The tripeptide glutathione (&#x3B3;-glutamylcysteinylglycine) is present in millimolar concentrations in the malaria parasite <italic>Plasmodium falciparum</italic> as well as in the host red blood cell (RBC) <xref ref-type="bibr" rid="pone.0007303-Beutler1">[1]</xref>&#x2013;<xref ref-type="bibr" rid="pone.0007303-Becker3">[5]</xref>. Reduced glutathione (GSH) plays an essential role in antioxidant defense in both parasite and host cell <xref ref-type="bibr" rid="pone.0007303-Beutler1">[1]</xref>&#x2013;<xref ref-type="bibr" rid="pone.0007303-Becker3">[5]</xref>. Parasite GSH supports cell growth by providing electrons for deoxyribonucleotide synthesis and takes part in detoxifying heme, a product of hemoglobin digestion <xref ref-type="bibr" rid="pone.0007303-Atamna1">[6]</xref>. Furthermore, GSH is the coenzyme of the glyoxalase system, which detoxifies methylglyoxal <xref ref-type="bibr" rid="pone.0007303-Akoachere1">[7]</xref>, and of glutathione <italic>S</italic>-transferase (GST)-based reactions. GSTs contribute to the detoxification of exogenous and endogenous cytotoxic metabolites. In <italic>Plasmodium</italic>, GST is involved in peroxide detoxification and the binding of parasitotoxic heme as well as in the development of drug resistance <xref ref-type="bibr" rid="pone.0007303-Hiller1">[8]</xref>. The flavoenzyme glutathione reductase (GR, EC 1.8.1.7) reduces oxidized glutathione (GSSG) back to GSH <xref ref-type="bibr" rid="pone.0007303-Becker1">[3]</xref>, <xref ref-type="bibr" rid="pone.0007303-KrauthSiegel1">[9]</xref>. Due to its central position in redox control, <italic>P. falciparum</italic> GR (<italic>Pf</italic>GR) is ranked number one in the list of proposed antimalarial drug targets for <italic>Plasmodium</italic> (<ext-link ext-link-type="uri" xlink:href="http://tdrtargets.org/">http://tdrtargets.org/</ext-link>), and a wide range of respective drug development approaches is currently being followed <xref ref-type="bibr" rid="pone.0007303-KrauthSiegel1">[9]</xref>&#x2013;<xref ref-type="bibr" rid="pone.0007303-Rahlfs1">[11]</xref>. In addition, the inhibition of RBC GR has been proposed as an approach to reduce the risk of multidrug resistance in malaria parasites <xref ref-type="bibr" rid="pone.0007303-KrauthSiegel1">[9]</xref>.</p>
      <p>In the GR-catalyzed reaction, reducing equivalents are provided by NADPH. NADPH is generated in the first half of the hexose monophosphate shunt by glucose-6-phosphate dehydrogenase (G6PD). Therefore, G6PD (producer of NADPH) as well as GR (utilizer of NADPH) are equally essential to maintain GSH homeostasis in the parasite-host unit <xref ref-type="bibr" rid="pone.0007303-Beutler2">[2]</xref>, <xref ref-type="bibr" rid="pone.0007303-Becker2">[4]</xref>. Mutations affecting either G6PD or GR might thus induce similar metabolic and functional consequences in the RBC. G6PD deficiency occurs in numerous genotypes, some of which are polymorphic and particularly frequent in areas where malaria is or was endemic <xref ref-type="bibr" rid="pone.0007303-Beutler3">[12]</xref>&#x2013;<xref ref-type="bibr" rid="pone.0007303-Greene1">[14]</xref>, affecting approximately 330 million people worldwide <xref ref-type="bibr" rid="pone.0007303-Nkhoma1">[15]</xref>. Decreased GR activity due to low saturation with FAD is also common in certain malaria-endemic regions <xref ref-type="bibr" rid="pone.0007303-Beutler4">[16]</xref>. By contrast, hereditary GR deficiency is rare <xref ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>, and only recently a full biochemical and molecular characterization of a GR mutation leading to complete GR deficiency has been performed <xref ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>. In this patient, RBCs and leukocytes did not contain any GR activity, and the GR protein could not be detected by Western blotting. DNA sequencing revealed a 2242-bp deletion, starting at nucleotide +658 in intron 11 and ending at nucleotide 639 in the 3&#x2032; untranslated region of exon 13 of the GR gene, which is located on chromosome 8. As a result, translated GR missed the complete dimerization domain, resulting in an inactive enzyme <xref ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>.</p>
      <p>In view of (a) the potentially similar metabolic effects of G6PD and GR deficiency, (b) the well documented protection from severe <italic>falciparum</italic> malaria afforded by G6PD deficiency <xref ref-type="bibr" rid="pone.0007303-Greene1">[14]</xref>, <xref ref-type="bibr" rid="pone.0007303-Ruwende1">[19]</xref> and (c) the fact that <italic>P. falciparum</italic> GR and human GR represent most promising antimalarial drug targets, we studied invasion and growth of several <italic>P. falciparum</italic> strains in GR-deficient RBCs as well as the stage-dependent pathological alterations induced by parasite growth in these erythrocytes. We directly compared those changes to GR-sufficient control cells as well as to analogous data obtained with malaria-infected G6PD-deficient RBCs and to senescent RBCs <xref ref-type="bibr" rid="pone.0007303-Luzzatto1">[13]</xref>, <xref ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>, <xref ref-type="bibr" rid="pone.0007303-Arese1">[21]</xref>. Analogies with RBCs from patients with sickle-cell trait, &#x3B2;-thalassemia <xref ref-type="bibr" rid="pone.0007303-Ayi1">[22]</xref>, and pyruvate kinase deficiency <xref ref-type="bibr" rid="pone.0007303-Ayi2">[23]</xref> are discussed.</p>
    </sec>
    <sec id="s2">
      <title>Results</title>
      <p>Unless otherwise indicated, all experiments reported below were performed with RBCs from the index patient.</p>
      <sec id="s2a">
        <title>Invasion and multiplication of P. falciparum grown in GR-deficient RBCs</title>
        <p>Twenty-four hours after inoculation of GR-deficient RBCs with malarial parasites (strains 3D7 or K1, experiment 1, see <xref ref-type="sec" rid="s4">Materials and Methods</xref>), ring stages of <italic>Plasmodium</italic> were detectable in all wells. As determined by Giemsa staining and by having an experienced technician count infected cells under the light microscope, the parasitemia for the 3D7 strain was 3.9&#xB1;0.5% in the GR-deficient cells and 4.0&#xB1;0.4% in the controls. This indicated that <italic>Plasmodium</italic> is able to invade GR-deficient RBCs as efficiently as normal RBCs. Subsequently, parasites were grown in the respective RBC cultures for four complete 48-h cycles, showing a mean multiplication rate of 4.9&#xB1;0.3 per RBC cycle for the GR-deficient RBCs, as well as 4.3 (0<sup>+</sup> blood) and 6.5 (A<sup>+</sup> blood) for the controls (mean 5.4&#xB1;0.5; data are given in <xref ref-type="table" rid="pone-0007303-t001">Table 1</xref>).</p>
        <table-wrap id="pone-0007303-t001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0007303.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Comparison of growth and biochemical properties of <italic>P. falciparum</italic> grown in GR-deficient and control RBCs.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0007303-t001-1" xlink:href="pone.0007303.t001"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">GR-deficient RBCs</td>
                  <td align="left" rowspan="1" colspan="1">Control RBCs</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="nt102">a</xref>Total glutathione in the parasite</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(3D7, exp. 1+2) [nmol/mg protein]</td>
                  <td align="left" rowspan="1" colspan="1">68&#xB1;2.1</td>
                  <td align="left" rowspan="1" colspan="1">73&#xB1;1.4</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="nt103">b</xref>GR activity in parasites [mU/mg]</td>
                  <td align="left" rowspan="1" colspan="1">160&#xB1;6</td>
                  <td align="left" rowspan="1" colspan="1">270&#xB1;14* (P&#x200A;=&#x200A;0.002)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Parasite multiplication rate per RBC</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">cycle (3D7, exp. 1))</td>
                  <td align="left" rowspan="1" colspan="1">4.9&#xB1;0.3</td>
                  <td align="left" rowspan="1" colspan="1">5.4&#xB1;0.5</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IC<sub>50</sub> chloroquine (3D7) [nM]</td>
                  <td align="left" rowspan="1" colspan="1">8.2&#xB1;0.2 (4.9&#xB1;0.2)</td>
                  <td align="left" rowspan="1" colspan="1">8.0&#xB1;0.2 (A<sup>+</sup>) (5.9&#xB1;0.6)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IC<sub>50</sub> chloroquine (K1) [nM]</td>
                  <td align="left" rowspan="1" colspan="1">160&#xB1;10</td>
                  <td align="left" rowspan="1" colspan="1">190&#xB1;11 (A<sup>+</sup>)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IC<sub>50</sub> methylene blue (3D7) [nM]</td>
                  <td align="left" rowspan="1" colspan="1">3.9&#xB1;0.2 (4.2&#xB1;0.3)</td>
                  <td align="left" rowspan="1" colspan="1">3.8&#xB1;0.2 (A<sup>+</sup>) (4.2&#xB1;0.3)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IC<sub>50</sub> methylene blue (K1) [nM]</td>
                  <td align="left" rowspan="1" colspan="1">8.8&#xB1;0.5</td>
                  <td align="left" rowspan="1" colspan="1">8.1&#xB1;0.4 (A<sup>+</sup>)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IC<sub>50</sub> artemisinin (3D7, exp. 2) [nM]</td>
                  <td align="left" rowspan="1" colspan="1">14&#xB1;0.5</td>
                  <td align="left" rowspan="1" colspan="1">16&#xB1;0.8</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IC<sub>50</sub> paraquat (3D7, exp. 2) [&#x3BC;M]</td>
                  <td align="left" rowspan="1" colspan="1">42&#xB1;2</td>
                  <td align="left" rowspan="1" colspan="1">53&#xB1;3* (P&#x200A;=&#x200A;0.04)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IC<sub>50</sub> SNP (3D7, exp. 2) [&#x3BC;M]</td>
                  <td align="left" rowspan="1" colspan="1">5.8&#xB1;0.3</td>
                  <td align="left" rowspan="1" colspan="1">11&#xB1;0.8* (P&#x200A;=&#x200A;0.006)</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt101">
              <label/>
              <p>Experiment 1 refers to the index patient and the A<sup>+</sup> blood group control, experiment 2 (data given in brackets or indicated as exp. 2) refers to index patient and mean values of 3 controls. All values given represent mean values &#xB1; SEM of the different individuals included and two to three parallel determinations per sample.</p>
            </fn>
            <fn id="nt102">
              <label>a</label>
              <p>Before determining the biochemical parameters in the parasites, <italic>P. falciparum</italic> was grown over 4&#x2013;5 cycles (corresponding to 8&#x2013;10 days) in the respective RBCs. Control cells had the same blood group (0<sup>+</sup>) as the patient's.</p>
            </fn>
            <fn id="nt103">
              <label>b</label>
              <p>*Indicates significant differences (P&lt;0.05) between GR-deficient cells and controls.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Also, in the second experiment (strain 3D7, see <xref ref-type="sec" rid="s4">Methods</xref>), all RBC samples (index patient and three controls) were efficiently invaded by the parasites. Forty-eight hours later about 4% infected RBCs (IRBCs) were again determined in all 4 cultures. After splitting and another 48-h cycle, a very similar parasitemia (given in the following for 3D7) was determined in all samples (9.8&#xB1;0.3% in the GR-deficient cells, 9.3&#xB1;0.4% in the controls). Also the percentages of ring stages (36&#xB1;2% in the patient and 37&#xB1;3% in the controls) and trophozoite/schizont stages (64&#xB1;1% in the patient, 62&#xB1;3% in the controls) did not differ significantly. The morphology of the parasites as determined by light microscopy after Giemsa staining was unchanged throughout the experiments (data not shown). In a separate set of experiments performed in the other participating laboratory in Turin with the Palo Alto parasite strain, similar data were obtained, showing that the invasion rate of GR-deficient RBCs was as high as that of control RBCs (30% parasitemia at 19 h after inoculation with 6.4% schizonts), and regular development into trophozoites was observed on day 2 (30% parasitemia).</p>
      </sec>
      <sec id="s2b">
        <title>GR activity, total glutathione content and drug sensitivity of P. falciparum grown in GR-deficient RBCs</title>
        <p>Malarial parasites grown in GR-deficient RBCs were tested for total glutathione content, GR activity, and their sensitivity towards redox-active antimalarials as well as inducers of oxidative and nitrosative stress. Data were collected in two independent experiments (including venipuncture and shipment of the blood samples) with different controls and two different parasite strains (K1 and 3D7). Before determining the above parameters, parasites were grown for 4&#x2013;5 cycles (corresponding to 8&#x2013;10 days) in the respective RBCs. Late trophozoite stages were then isolated as described in the <xref ref-type="sec" rid="s4">Materials and Methods</xref> section and directly used for the determination of GR activity and glutathione content. Antimalarial drugs and pro-oxidant agents were added to the ring stages of the parasites in order to determine their IC<sub>50</sub> values.</p>
        <p>In both experiments the parasites displayed a glutathione content of about 70 nmol/mg protein, which did not differ between parasites grown in GR-deficient and normal host cells (<xref ref-type="table" rid="pone-0007303-t001">Table 1</xref>). However, in the parasites grown in GR-deficient cells, GR activity was found to be significantly reduced to 61% (experiment 1, see <xref ref-type="table" rid="pone-0007303-t001">Table 1</xref>) of control values. A comparable value (66% of control activity) was determined in experiment 2.</p>
        <p>The IC<sub>50</sub> values for CQ, artemisinin, and methylene blue were very similar between parasites grown in GR-deficient RBCs and in normal control RBCs (<xref ref-type="table" rid="pone-0007303-t001">Table 1</xref>). This was verified in both experiments and for both parasite strains K1 and 3D7. However, the IC<sub>50</sub> values of the superoxide generating agent paraquat and of sodium nitroprusside were found to be significantly lower in parasites grown in GR-deficient RBCs than in controls (<xref ref-type="table" rid="pone-0007303-t001">Table 1</xref>).</p>
      </sec>
      <sec id="s2c">
        <title>Membrane binding of hemichromes, complement C3 fragment, autologous IgG, and phagocytosis in ring stage-infected GR-deficient RBCs</title>
        <p>Membrane-bound hemichromes, indicators of oxidative membrane damage and inducers of RBC membrane modifications producing enhanced phagocytosis <xref ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>&#x2013;<xref ref-type="bibr" rid="pone.0007303-Ayi1">[22]</xref>, were measured in ring stage-infected RBCs of the index patient, individual 2 (brother), and individual 3 (sister), all homozygous for the GR deficiency, and were compared to ring stage-infected normal RBCs. As shown in <xref ref-type="fig" rid="pone-0007303-g001">Fig. 1A</xref>, parasite growth significantly increased membrane-bound hemichromes in all three GR-deficient individuals.</p>
        <fig id="pone-0007303-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0007303.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Membrane-bound hemichromes, complement C3c fragment, and autologous IgG in GR-deficient and GR-sufficient RBCs.</title>
            <p>Shown are membrane-bound hemichromes (panel A), complement C3c fragment (panel B) and autologous IgG (panel C) in ring-infected and non-infected GR-deficient RBCs from the index patient, brother (individual 2) and sister (individual 3) of index patient, and from normal GR-sufficient controls. Black bars indicate ring-infected RBCs; open bars, non-infected RBCs. Hemichromes are expressed as pmoles/&#xB5;g membrane protein. Mean values of index patient, individuals 2 and 3, and normal controls (mean&#xB1;SD, n&#x200A;=&#x200A;2&#x2013;4) are shown. Hemichromes were significantly higher (p&lt;0.02) in the ring-infected RBCs of the index patient and individuals 2 and 3 compared to ring-infected RBCs of normal controls. Complement C3c fragment and autologous IgG are expressed as Mean Fluorescence Intensity. Representative data of GR-deficient individuals and mean values of normal controls (mean&#xB1;SD, n&#x200A;=&#x200A;2&#x2013;3). For experimental details see <xref ref-type="sec" rid="s4">Materials and Methods</xref>.</p>
          </caption>
          <graphic xlink:href="pone.0007303.g001"/>
        </fig>
        <p>Membrane binding of complement fragments C3 and C3b<sub>2</sub> and autologous IgG, two powerful opsonins known to be instrumental in inducing phagocytosis, were assayed in ring-infected RBCs in the index patient as well as in individuals 2 and 3. Opsonic complement C3 fragments C3b/C3b<sub>2</sub> were measured as C3c, a stable C3 derivative, making use of anti-C3c antibodies, as detailed in the <xref ref-type="sec" rid="s4">Materials and Methods</xref> section. As shown in <xref ref-type="fig" rid="pone-0007303-g001">Figure 1B&#x2013;C</xref>, membrane deposition of complement fragment C3c was remarkably increased in all three GR-deficient individuals, while binding of IgG was strongly enhanced in the index patient but unchanged in the other two individuals. In general, changes observed in the index patient were more pronounced compared to the other two GR-deficient individuals. Phagocytosis was assayed with the human monocytic cell line THP-1 (<xref ref-type="fig" rid="pone-0007303-g002">Figure 2A</xref>) and with human mononuclear cells (<xref ref-type="fig" rid="pone-0007303-g002">Figure 2B</xref>). Both phagocytic cell types displayed increased phagocytosis of ring-infected cells from all three GR-deficient individuals. Again the effect was more pronounced in the index patient. Co-cultivated, non-infected normal or deficient RBCs were not phagocytosed in significant amounts (<xref ref-type="fig" rid="pone-0007303-g002">Figure 2A&#x2013;B</xref>). Trophozoites were phagocytosed more intensely than ring stages, with minor differences between GR-deficient and control RBCs (<xref ref-type="fig" rid="pone-0007303-g002">Figure 2B</xref>).</p>
        <fig id="pone-0007303-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0007303.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Phagocytosis of GR-deficient and GR-sufficient RBCs.</title>
            <p>Shown is the phagocytosis by THP-1 cells (panel A) of ring-infected and non-infected GR-deficient RBCs from the index patient, brother (individual 2) and sister (individual 3) of the index patient, and from normal GR-sufficient controls. Phagocytosis by human monocytes (panel B) of ring- and trophozoite-infected and non-infected GR-deficient RBCs from the index patient, brother (individual 2) of the index patient, and from normal GR-sufficient controls. Black bars indicate ring-/trophozoite-infected RBCs; open bars, non-infected RBCs. Phagocytosis is expressed as the number of ingested RBCs per phagocyte. Representative data of index patient, individuals 2 and 3, and mean values of normal controls (mean&#xB1;SD, n&#x200A;=&#x200A;3) are shown. For experimental details see <xref ref-type="sec" rid="s4">Materials and Methods</xref>.</p>
          </caption>
          <graphic xlink:href="pone.0007303.g002"/>
        </fig>
        <p>The data on membrane-bound hemichromes, complement C3c fragment, IgG, and phagocytosis were obtained from single samples from the GR-deficient individuals and 3&#x2013;4 normal controls. Except for hemichromes where 3&#x2013;4 repeats were constantly performed and formal statistical treatment was possible, the paucity of sample material did not allow us to perform a sufficient number of repeats in the GR-deficient samples. Therefore representative values are shown in <xref ref-type="fig" rid="pone-0007303-g001">Figures 1</xref> and <xref ref-type="fig" rid="pone-0007303-g002">2</xref>. The supplementary <xref ref-type="supplementary-material" rid="pone.0007303.s001">figure S1</xref> compares results shown in <xref ref-type="fig" rid="pone-0007303-g001">Figures 1</xref> and <xref ref-type="fig" rid="pone-0007303-g002">2</xref> with an additional series of normal control rings obtained using 24&#x2013;36 h old normal blood from 7 healthy Italian donors. In general, SDs were distinctly lower in the Italian control series, increasing the robustness of comparisons.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Discussion</title>
      <sec id="s3a">
        <title>RBC mutations leading to enhanced ring phagocytosis</title>
        <p>A relatively small number of mutations affecting hemoglobins and RBC enzymes are present in large numbers in human populations. It is accepted that these widespread polymorphisms afford protection against <italic>falciparum</italic> malaria <xref ref-type="bibr" rid="pone.0007303-Williams1">[24]</xref>&#x2013;<xref ref-type="bibr" rid="pone.0007303-MinOo1">[26]</xref>. A group of these conditions including sickle cell anemia, &#x3B2;-thalassemia, possibly hemoglobins C <xref ref-type="bibr" rid="pone.0007303-Arie1">[27]</xref>, <xref ref-type="bibr" rid="pone.0007303-Tokumasu1">[28]</xref> and E <xref ref-type="bibr" rid="pone.0007303-Chotivanich1">[29]</xref>, as well as G6PD deficiency <xref ref-type="bibr" rid="pone.0007303-Greene1">[14]</xref>, <xref ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref> and PK deficiency <xref ref-type="bibr" rid="pone.0007303-Ayi2">[23]</xref> appear to provide antimalarial protection based on a common mechanism <xref ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>, <xref ref-type="bibr" rid="pone.0007303-Ayi1">[22]</xref>. The aberrant RBCs are characterized by an increased production of reactive oxygen species (ROS) (hemoglobin mutants), or decreased antioxidant defense (G6PD deficiency, PK deficiency <xref ref-type="bibr" rid="pone.0007303-Ayi2">[23]</xref>). Non-infected, mutant RBCs display slight but significantly increased membrane deposition of hemichromes accompanied by low-grade but distinct enhancement of phagocytic uptake <xref ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>, <xref ref-type="bibr" rid="pone.0007303-Ayi1">[22]</xref>, <xref ref-type="bibr" rid="pone.0007303-Ayi2">[23]</xref>. Parasites growing in any of the aforementioned mutated cells induce typical modifications in the host RBCs which start manifesting at ring stage. Normal RBCs harboring ring stages show little band 3 aggregation, poor opsonization, and slightly enhanced phagocytic recognition and uptake <xref ref-type="bibr" rid="pone.0007303-Turrini1">[30]</xref>. By contrast, rings growing in mutant RBCs sequentially display (1) remarkably enhanced hemichrome deposition on the membrane, (2) oxidative band 3 aggregation, (3) increased affinity for naturally circulating IgG &#x2013; notably anti-(band 3) IgG, (4) activation of the complement system and generation of C3 opsonic fragments, (5) opsonization by increased deposition of autologous IgG and C3 opsonic fragments, and finally (6) remarkably enhanced recognition and phagocytosis by monocytes/macrophages <xref ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>&#x2013;<xref ref-type="bibr" rid="pone.0007303-Ayi2">[23]</xref>. This sequence of events, eventually resulting in enhanced phagocytic uptake, is very similar to changes occurring in the normal human RBC during the very last phase of its lifespan of 120&#xB1;4 days <xref ref-type="bibr" rid="pone.0007303-Arese1">[21]</xref>.</p>
      </sec>
      <sec id="s3b">
        <title>Advantages of enhanced ring phagocytosis for the malaria patient</title>
        <p>Enhanced and preferential phagocytosis of ring-parasitized mutant RBCs may be advantageous to the host in two ways: (i) <italic>via</italic> reduction of parasite growth and parasite density, observed for example in patients with HbAS and &#x3B2;-thalassemia trait <xref ref-type="bibr" rid="pone.0007303-Williams1">[24]</xref>, <xref ref-type="bibr" rid="pone.0007303-Roberts1">[25]</xref>, and (ii) <italic>via</italic> rapid digestion of phagocytosed rings by monocytes and the frequent repetition of this process without loss of efficiency <xref ref-type="bibr" rid="pone.0007303-Schwarzer1">[31]</xref>. By contrast, phagocytosis of hemozoin-containing mature parasites inhibits the ability of monocytes to repeat the phagocytic process <xref ref-type="bibr" rid="pone.0007303-Schwarzer1">[31]</xref>, enhances their production of inflammatory cytokines <xref ref-type="bibr" rid="pone.0007303-Hnscheid1">[32]</xref>, and impairs their ability to kill ingested pathogens <xref ref-type="bibr" rid="pone.0007303-Fiori1">[33]</xref>, to express MHC class II and other membrane antigens upon interferon-gamma stimulation <xref ref-type="bibr" rid="pone.0007303-Schwarzer2">[34]</xref>, and to correctly present antigens <xref ref-type="bibr" rid="pone.0007303-Scorza1">[35]</xref>. Another way enhanced ring phagocytosis may be advantageous to the host is by lowering the number of trophozoites and schizonts adhering to endothelia in specific organs and provoking there severe clinical conditions such as cerebral malaria, placental malaria, and possibly dyserythropoiesis-based anemia <xref ref-type="bibr" rid="pone.0007303-Skorokhod1">[36]</xref>, <xref ref-type="bibr" rid="pone.0007303-Chakravorty1">[37]</xref>. Other protection mechanisms probably concur with this based on enhanced ring-phagocytosis of mutant RBCs underscored here. For example, decreased adhesion to endothelia has been suggested to be involved in anti-malaria defense in sickle-cell trait <xref ref-type="bibr" rid="pone.0007303-Cholera1">[38]</xref>, <xref ref-type="bibr" rid="pone.0007303-Fairhurst1">[39]</xref> and Hb AC/CC <xref ref-type="bibr" rid="pone.0007303-Fairhurst2">[40]</xref>.</p>
      </sec>
      <sec id="s3c">
        <title>ApoGR-deficient red blood cells as host cells for P. falciparum</title>
        <p>GR deficiency and G6PD deficiency might show similar characteristics as far as instability and impaired regeneration of GSH from GSSG is concerned <xref ref-type="bibr" rid="pone.0007303-Arese2">[41]</xref>, <xref ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>. However, G6PD deficiency may have more severe functional consequences for the RBC than GR deficiency, since insufficient formation of NADPH leads to an inadequate supply of reducing equivalents to both the glutathione and the thioredoxin system, whereas the absence of GR activity in non-parasitized RBCs is obviously well compensated <xref ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>. As indicated already by previous studies, rather stable GSH concentrations are present in the non-parasitized RBCs <xref ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>. This might be due to enhanced GSH synthesis <xref ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref> but could also be the result of upregulation of the pentose phosphate shunt and by components of the thioredoxin system. Also in the host-parasite unit, the absence of RBC GR seems to be well tolerated under cell culture conditions and in the absence of oxidative stressors. This is shown by normal invasion and growth as well as by comparable glutathione levels detected in both parasites grown in GR-deficient and normal RBCs. Interestingly, GR activity was found to be downregulated by 40% in the parasite compartment. The observation that this decrease is not reflected in the glutathione levels can be explained by the fact that GR is working intracellularly with large spare capacity <xref ref-type="bibr" rid="pone.0007303-KrauthSiegel1">[9, and references therein]</xref>. This phenomenon, however, needs to be studied in further detail. An efficient adaptation to the lack of host cell GR in our <italic>in vitro</italic> system was furthermore supported by the fact that the IC<sub>50</sub> values for CQ, artemisinin, and methylene blue were very similar when comparing parasites grown in GR-deficient RBCs and in GR-sufficient control RBCs. All three antimalarial drugs are known to interfere with redox metabolism: CQ inhibits heme polymerization, leading to enhanced oxidative stress; artemisinin as an endoperoxide is able to increase ROS concentrations; methylene blue is a known redox cycler and <italic>Pf</italic>GR inhibitor <xref ref-type="bibr" rid="pone.0007303-Becker2">[4]</xref>, <xref ref-type="bibr" rid="pone.0007303-Becker3">[5]</xref>. Only when incubating parasitized RBCs with micromolar concentrations of paraquat <xref ref-type="bibr" rid="pone.0007303-KomakiYasuda1">[42]</xref> or of the nitric oxide releasing agent sodium nitroprusside, IC<sub>50</sub> values were significantly lower in parasites grown in GR-deficient RBCs than in the controls. This result suggests that it might be possible to demonstrate the higher redox susceptibility of GR-deficient parasitized RBCs in an <italic>in vitro</italic> assay by imposing oxidative or nitrosative stress.</p>
      </sec>
      <sec id="s3d">
        <title>Enhanced ring phagocytosis associated with GR deficiency</title>
        <p>Data presented here show that malaria-infected GR-deficient RBCs behave very similarly to infected G6PD-deficient RBCs <xref ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>. First, GR-deficient RBCs were invaded by parasites, and they supported the growth and multiplication of CQ-sensitive and -resistant <italic>P. falciparum</italic> strains in a manner similar to normal RBCs. Second, as expected from the enhanced sensitivity to oxidation, infection enhanced heme and hemichrome deposition in deficient RBCs by a factor of approximately 3. Third, membrane deposition of opsonins such as C3 complement fragments and autologous IgG, and phagocytosis, were also found to be increased when ring stages were grown in GR-deficient RBCs. The two other homozygous GR-deficient individuals examined here (brother and sister of the index patient) also showed enhanced binding of C3 complement fragment and increased phagocytosis whereas IgG binding was not increased. These differences remain to be elucidated in further detail. All three individuals studied were identical with respect to the complete lack of GR activity. However, other metabolic or immunologic states and predispositions, which we do not know and therefore cannot control, might lead to the observed differences.</p>
      </sec>
      <sec id="s3e">
        <title>Endemic GR deficiency caused by undersaturation with FAD</title>
        <p>Complete absence of RBC GR is very rare <xref ref-type="bibr" rid="pone.0007303-Beutler3">[12]</xref>, <xref ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>, <xref ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>. This defect evidently did not arise in parallel to malaria expansion in humans to provide protection. However, impairment of GR activity is widespread and geographically coincident with past or present occurrence of malaria. Since GR is a flavoprotein critically dependent on FAD <xref ref-type="bibr" rid="pone.0007303-Schulz1">[43]</xref>, flavin-deficient RBCs would contain decreased GR activity. In fact, riboflavin deficiency is widespread in underdeveloped countries due to low dietary intake <xref ref-type="bibr" rid="pone.0007303-Ahmed1">[44]</xref>, <xref ref-type="bibr" rid="pone.0007303-Rohner1">[45]</xref>. Several studies have shown that a reduced riboflavin status and non-genetic low GR activity are associated with lower <italic>Plasmodium</italic> parasitemia in humans <xref ref-type="bibr" rid="pone.0007303-Das1">[46]</xref> and in animal <xref ref-type="bibr" rid="pone.0007303-Kaikai1">[47]</xref> models and are frequently found in malaria-endemic areas <xref ref-type="bibr" rid="pone.0007303-Anderson1">[48]</xref>. Furthermore, high prevalence of familial flavin-deficient RBCs not due to dietary riboflavin deficiency was detected in parts of Italy where malaria used to be prevalent, namely the Maremma region in Tuscany, the delta region of the river Po, and coastal areas in Sardinia <xref ref-type="bibr" rid="pone.0007303-Anderson1">[48]</xref>&#x2013;<xref ref-type="bibr" rid="pone.0007303-Anderson3">[50]</xref>. Interestingly, in Sardinia <xref ref-type="bibr" rid="pone.0007303-Anderson3">[50]</xref> micro-regional accumulation in villages formerly exposed to malaria was observed for carriers of the putative malaria-protective low-activity GR and FMN-dependent pyridoxine phosphate oxidase <xref ref-type="bibr" rid="pone.0007303-Anderson3">[50]</xref>. Accumulation in the same villages was previously observed for carriers of &#x3B2;-thalassemia and G6PD deficiency <xref ref-type="bibr" rid="pone.0007303-Siniscalco1">[51]</xref>. Finally, low GR activity was found to be frequently associated with other malaria-protective mutations such as sickle-cell anemia and &#x3B2;-thalassemia <xref ref-type="bibr" rid="pone.0007303-ElHazmi1">[52]</xref>&#x2013;<xref ref-type="bibr" rid="pone.0007303-Varma1">[55]</xref>.</p>
      </sec>
      <sec id="s3f">
        <title>Conclusions</title>
        <p>In conclusion, rare RBC mutations such as PK deficiency and GR deficiency resist malaria infection and may provide protection by the same paradigm applicable to widespread mutations such as those affecting hemoglobin, G6PD, or membrane proteins. Thus the pharmacologic inhibition of parasite and/or host cell GR might lead to metabolic consequences proven by nature to be effective against the parasite. Indeed the inhibition of RBC GR has been proposed as a feasible antimalarial approach likely to reduce the risk of resistance development <xref ref-type="bibr" rid="pone.0007303-KrauthSiegel1">[9]</xref>. Normal RBCs pretreated with high doses of the cytostatic agent carmustine (BCNU) have no detectable GR activity. These RBCs do not serve as host cells of <italic>P. falciparum in vitro</italic> unless the medium contains high levels of glutathione. Thus, in contrast to genetically GR-deficient RBCs, RBCs rendered GR-deficient by BCNU appear to be unable to maintain sufficient GSH levels, possibly because the high BCNU doses also affect the GSH synthesizing enzymes <xref ref-type="bibr" rid="pone.0007303-Zhang1">[56]</xref>. Nevertheless erythrocytes pretreated with lower doses of nitrosoureas <italic>in vivo</italic> or <italic>in vitro</italic> are probably suitable for corroborating and extending the findings of this present study <xref ref-type="bibr" rid="pone.0007303-Frischer1">[57]</xref>.</p>
        <p>When testing GR-inhibitors as antiplasmodial agents it should be taken into account that the effects on parasite growth and multiplication <italic>in vitro</italic> might be less pronounced than <italic>in vivo</italic> &#x2013; as observed in genetic GR deficiency. Thus additional tests such as parallel application of oxidant stressors and/or determination of membrane alterations and phagocytosis should be performed for assessing the antimalarial effects of GR inhibitors. Furthermore their hemolytic potential needs to be evaluated carefully.</p>
      </sec>
    </sec>
    <sec sec-type="materials|methods" id="s4">
      <title>Materials and Methods</title>
      <sec id="s4a">
        <title>Patients</title>
        <p>The GR-deficient patient &#x2013; the index patient &#x2013; who kindly agreed to donate blood for this study was a 54-year old woman whose clinical history has been described before <xref ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>, <xref ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>. She was the index patient in a family with GR deficiency who suffered a hemolytic crisis after eating fava beans. Two siblings &#x2013; brother and sister of the index patient, indicated as individual 2 and individual 3, respectively &#x2013; were also homozygous for GR deficiency <xref ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>. In all three individuals GR activity in RBCs and leukocytes was undetectable and could not be stimulated by either riboflavin ingestion <italic>in vivo</italic> or FAD addition <italic>in vitro</italic> <xref ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>.</p>
        <p>All family members included in this study are fully aware of their unique enzyme deficiency and have given their written consent for the research carried out. The research has been explained to them both in written and oral form. The research was performed as part of the diagnostic work on the patients' blood samples, which is fully approved by the Sanquin Ethical Medical Committee.</p>
      </sec>
      <sec id="s4b">
        <title>GR activity in GR-deficient, non-infected RBCs and GR-deficient leukocytes</title>
        <p>As previously reported, the GR activity in the patients' non-infected RBCs was below the detection limit of our assay, while leukocytes had 15% of normal activity. However, taking into account the basal NADPH oxidation rate measured in the absence of GSSG (14&#x2013;63 &#xB5;moles/min/10<sup>11</sup> cells at 25&#xB0;C), only minimal GR activity was present in patient's or her siblings' leukocytes (&lt;5 &#xB5;moles/min/10<sup>11</sup> cells at 25&#xB0;C) <xref ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>. Furthermore neither non-infected RBCs nor leukocytes of the patient or her siblings contained detectable amounts of GR protein. In direct comparison, healthy adult control persons (n&#x200A;=&#x200A;100) had GR activities of 2.7&#x2013;5.8 IU/g hemoglobin in RBCs and 118&#x2013;164 IU/10<sup>11</sup> leukocytes <xref ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>.</p>
        <p>GSH levels were already measured and reported for the GR-deficient patients in 1976. GSH was measured in the red cells of all family members and found to be normal, with values of 56&#x2013;63 mg of GSH per 100 ml of packed red cells <xref ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>.</p>
      </sec>
      <sec id="s4c">
        <title>Preparation and shipment of blood samples</title>
        <p>For the studies performed in Giessen (infection by 3D7 and K1 <italic>P. falciparum</italic> strains, parasite cultivation, synchronization, invasion and multiplication studies, determination of glutathione and enzyme activities in parasites, drug sensitivity tests), EDTA-blood samples were taken from the patients and from hematologically healthy control persons in the Netherlands, immediately shipped to Germany on crushed ice, and utilized within 24 h. For the studies performed in Turin (infection by the Palo Alto <italic>P. falciparum</italic> strain and parasite cultivation, invasion and multiplication studies, synchronization of parasite cultures and stage-dependent separation of infected RBCs, quantification of membrane-bound total heme, hemichromes, IgG and complement C3c fragment, assay of phagocytosis with stage-separated infected and control RBCs), full blood from the GR-deficient individuals and three normal controls was anticoagulated with CPD, shipped on crushed ice, and utilized within 24 h of venipuncture. The further processing of the blood samples is described below.</p>
      </sec>
      <sec id="s4d">
        <title>Cultivation of P. falciparum and preparation of parasite extracts</title>
        <p>In the Giessen lab CQ sensitive (3D7-Netherlands) and resistant (K1-Southeast Asia) strains of <italic>P. falciparum</italic> were grown in continuous culture as described <xref ref-type="bibr" rid="pone.0007303-Trager1">[58]</xref> with slight modifications. Parasites were maintained at 1&#x2013;10% parasitemia and 3.3% hematocrit in RPMI 1640 culture medium supplemented with A<sup>+</sup> RBCs (normal culture conditions) or 0<sup>+</sup> RBCs (for the GR-deficient patient and a control sample), 4% A<sup>+</sup> human serum, 0.2% lipid-rich bovine serum albumin (Albumax), 9 mM glucose, 0.2 mM hypoxanthine, 2.1 mM L-glutamine, and 22 &#xB5;g/ml gentamicin. All incubations were carried out at 37&#xB0;C, 3% O<sub>2</sub>, 3% CO<sub>2</sub> and 94% N<sub>2</sub>. Synchronization of parasites in culture to ring stages was carried out by treatment with 5% (w/v) sorbitol <xref ref-type="bibr" rid="pone.0007303-Lambros1">[59]</xref>. The morphology of the parasites as well as the multiplication rate were determined by light microscopy after Giemsa staining. Before determining either the glutathione content or the GR activity in <italic>P. falciparum</italic>, parasites were grown over 5 cycles (10 days) in their respective RBCs. Trophozoite stage parasites were then isolated by suspending the RBCs in a 20-fold volume of buffer containing 7 mM K<sub>2</sub>HPO<sub>4</sub>, 1 mM NaH<sub>2</sub>PO<sub>4</sub>, 11 mM NaHCO<sub>3</sub>, 58 mM KCl, 56 mM NaCl, 1 mM MgCl<sub>2</sub>, 14 mM glucose, and 0.02% saponin for 10 min at 37&#xB0;C. The pellets were washed two times in the same saponin buffer for RBC lysis and one time in PBS (centrifugation for all steps 1,500 g, 5 min, room temperature). The free parasites were finally diluted in PBS and disrupted by freezing and thawing three times in the presence of protease inhibitors (40 &#xB5;l/ml Complete (Roche) and 1 mg/ml Pefabloc (Roche)). After centrifugation (ultracentrifuge 100,000 g, 30 min, 4&#xB0;C), the protein content of the supernatant was determined by the Bradford method and the extract was used for the various analyses.</p>
      </sec>
      <sec id="s4e">
        <title>Invasion and multiplication of P. falciparum grown in GR-deficient RBCs</title>
        <p>To determine if <italic>P. falciparum</italic> can successfully invade and multiply in GR-deficient RBCs, EDTA full blood was taken from patients and controls in the Netherlands and shipped at 4&#xB0;C to the Giessen lab. About 24 h after venipuncture, plasma and buffy coat of the blood samples were removed by centrifugation (1,500 g) and aspiration followed by washing three times in a 10-fold volume of RPMI 1640 medium (1,500 g, 3 min, 4&#xB0;C). For some of the invasion studies control samples freshly taken in Germany were processed and studied in parallel.</p>
        <p>EXPERIMENT 1: Ten &#xB5;l of RBCs from the index patient (0<sup>+</sup> blood) and two German controls (A<sup>+</sup> and 0<sup>+</sup> blood) each were added to 300 &#xB5;l of complete cell culture medium in 48-well plates. Two &#xB5;l of parasitized RBCs (3D7, mainly trophozoite stage; final parasitemia 0.7%) were added to the RBC cultures. The K1 strain was inoculated for drug sensitivity tests.</p>
        <p>EXPERIMENT 2: In a separate experiment, RBCs from the index patient (0<sup>+</sup> blood) were shipped together with 3 controls (0<sup>+</sup>, A<sup>+</sup>, A<sup>+</sup> blood). After washing, 0.5 ml of RBCs were added to 15 ml of cell culture medium and inoculated with 1 ml of parasitized RBCs (3D7, synchronized to ring stages; this resulted in the same final parasitemia of 0.7% as in experiment 1).</p>
      </sec>
      <sec id="s4f">
        <title>Determination of total glutathione and PfGR activity in parasite extracts</title>
        <p>For the determination of total glutathione content, 40 &#xB5;l of parasite extract was deproteinized by adding 2 vol of 5% (w/vol) sulfosalicylic acid; the samples were mixed and centrifuged, and the supernatant was used for analyses. The glutathione content was measured by the GR-coupled 5,5&#x2032;-dithio-bis(2-nitrobenzoic acid, DTNB)-GSH-recycling assay <xref ref-type="bibr" rid="pone.0007303-Becker4">[60]</xref>. A standard curve was prepared using appropriate concentrations of GSH and sulfosalicylic acid. <italic>P. falciparum</italic> (<italic>Pf</italic>)GR activity in the parasite extracts was assayed at 25&#xB0;C with 100 &#xB5;M NADPH and 1 mM GSSG in 47 mM potassium phosphate, 200 mM KCl, 1 mM EDTA, pH 6.9. The consumption of NADPH was followed spectrophotometrically at 340 nm <xref ref-type="bibr" rid="pone.0007303-Nordhoff1">[61]</xref>. Specific activities (&#xB5;mol/min/mg of protein) were calculated using the enzyme activities at 25&#xB0;C and the protein concentrations of the parasite extracts.</p>
      </sec>
      <sec id="s4g">
        <title>Drug effects on P. falciparum</title>
        <p>An isotopic drug sensitivity assay using the semi-automated microdilution technique <xref ref-type="bibr" rid="pone.0007303-Desjardins1">[62]</xref> was employed to investigate the effects of CQ, artemisinin, methylene blue, paraquat and sodium nitroprusside (SNP) on parasites grown in GR-deficient RBCs. The method is based on the incorporation of radioactive <sup>3</sup>H-hypoxanthine &#x2013; which is taken up by the parasite as a precursor of purine deoxynucleotides for DNA and RNA synthesis &#x2013; and was modified according to Fivelman <xref ref-type="bibr" rid="pone.0007303-Fivelman1">[63]</xref>. In 96-well microtiter plates (Nunc<sup>R</sup>), a two-fold serial dilution of the starting concentration of each drug to be tested was carried out. Parasites were incubated at a parasitemia of 0.125% (&gt;70% ring forms) and 1.25% hematocrit in hypoxanthine-free medium. After 48 h, 0.5 &#xB5;Ci <sup>3</sup>H-hypoxanthine was added into each well and the plates were incubated for another 24 h. The cells from each well were harvested on a glass fiber filter (Perkin-Elmer, Rodgau-J&#xFC;gesheim, Germany), washed, and dried. Their radioactivity in counts per min was considered to be proportional to the respective growth of <italic>P. falciparum</italic> in the well. IC<sub>50</sub> values (drug concentrations that produce 50% reduction in the uptake of <sup>3</sup>H-hypoxanthine) were calculated as described in <xref ref-type="bibr" rid="pone.0007303-Fivelman1">[63]</xref>.</p>
        <p>For statistical analyses of the data on multiplication rates, biochemical parameters and IC<sub>50</sub> values (given as mean values &#xB1; SEM), the unpaired t-test as well as the Mann-Whitney U Test were employed.</p>
      </sec>
      <sec id="s4h">
        <title>Stage-dependent separation and opsonization of parasites</title>
        <p><italic>P. falciparum</italic> parasites (Palo Alto strain, <italic>Mycoplasma-</italic>free) were cultivated in normal and GR- deficient RBCs at 2% hematocrit and synchronized as described <xref ref-type="bibr" rid="pone.0007303-Turrini1">[30]</xref>. Briefly, schizont stage infected normal RBCs (parasitemia &gt;95%) were mixed for invasion with washed GR-deficient or normal RBCs and kept in growth medium (RPMI 1640, containing 25 mM Hepes, 30 mM glucose, 2 mM glutamine, 0.02 mM adenine, 24 mM NaHCO<sub>3</sub>, 32 mg/l gentamicin, and 10% A<sup>+</sup> decomplemented human plasma) (time 0). After 19 h incubation in a humidified CO<sub>2</sub>/air incubator, the ring-enriched fraction was separated on and collected from a discontinuous 40/80/90% Percoll gradient, containing mannitol (6% wt/vol). The bottom Percoll fraction contained non-infected RBCs and approximately 15&#x2013;20% rings, morphologically identical to those of the ring-enriched fraction. After 41 h incubation the trophozoite-enriched fraction was separated onto and collected from a discontinuous 10/40/80% Percoll gradient. Rings (after 19 h incubation) as well as trophozoites (after 41 h incubation) were enriched to approx. 80&#x2013;85% and approx. 90%, respectively, by the above procedure. Parasitemia and parasite morphology were assessed by light microscopy after Diff-Quik&#xAE; Fix staining (Medion Diagnostics GmbH, D&#xFC;dingen, Switzerland). Non-infected control RBCs of each donor were incubated and treated in a similar way without schizont inoculation at time 0. Infected and non-infected RBCs were washed, rejuvenated for 1 h in PBS-G, and opsonized with freshly drawn serum of a healthy AB/Rh<sup>+</sup>-donor in a ratio: RBCs/PBS containing 2 mM glucose (PBS-G)/serum 1/1/2 (vol/vol). Non-opsonized RBCs were incubated in parallel substituting serum with PBS-G. After 30 min at 37&#xB0;C cells (ring-enriched, trophozoite-enriched or non-infected RBCs) were washed 3 times with PBS-G, adjusted to 50% hematocrit and analyzed by FACS for surface-bound IgG and complement C3c fragment, and utilized for the phagocytosis assays with THP-1 cells and human peripheral monocytes. Total heme and hemichromes were measured in hypotonic ghosts prepared from the bottom Percoll fraction of the unseparated, infected GR-deficient and normal RBCs (see below). The latter procedure was due to the paucity of the ring material obtained by the enriched ring fraction (approx. 30&#x2013;40 &#xB5;l per individual) sufficient to perform cytofluorimetric studies but not sufficient for ghost preparation.</p>
      </sec>
      <sec id="s4i">
        <title>Quantification of membrane-bound total heme and hemichromes in ghosts prepared from stage-separated infected RBCs</title>
        <p>Heme bound to the cytoplasmic face of the membrane as hemoglobin and insoluble hemichromes was analyzed in the hypotonic ghosts <xref ref-type="bibr" rid="pone.0007303-Steck1">[64]</xref> prepared under non-reducing conditions in the presence of Complete&#xAE; protease inhibitor cocktail from the bottom Percoll fraction of the unseparated, infected GR-deficient and normal RBCs <xref ref-type="bibr" rid="pone.0007303-Ayi1">[22]</xref>. This fraction contained approximately 15&#x2013;20% rings. Every ghost preparation was divided into two aliquots. A first aliquot of 10 &#xB5;l ghosts was solubilized for 3 h at 4&#xB0;C in 1 ml of 0.1 N NaOH containing 3 mM EDTA and 0.05% (vol/vol) Triton X100 to quantify the total heme content (hemoglobin + insoluble hemichromes). A second aliquot of 10 &#xB5;l ghosts was solubilized for 1 h at room temperature in 1 ml of PBS containing 3 mM EDTA and 0.05% (vol/vol) Triton X100 and used to quantify hemoglobin. Heme from both ghost aliquots was quantified by measuring the heme-dependent luminol-enhanced luminescence as described <xref ref-type="bibr" rid="pone.0007303-Schwarzer3">[65]</xref>. Each luminescence measurement (2 &#xB5;L aliquots) was repeated 3&#x2013;4 times. Inter-measurement variability never exceeded 2&#x2013;3%. <xref ref-type="sec" rid="s2">Results</xref> obtained from cell samples that contained approx. 15&#x2013;20% rings were extrapolated to 100% rings using the calculation suggested by Cappadoro <italic>et al.</italic> <xref ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>. The hemichrome content was calculated from the difference between total heme and hemoglobin heme. Hemichrome heme was the major component of total heme in control rings (88% of total heme), index patient (96%), individual 2 (89%) and individual 3 (87%), while membrane-bound hemoglobin was a minor fraction of total heme.</p>
      </sec>
      <sec id="s4j">
        <title>Quantification of complement C3c fragment and IgG by flow cytometry</title>
        <p>Ten million ring- or trophozoite-infected and non-infected normal or GR-deficient RBCs were incubated for 30 min at room temperature in 50 &#xB5;l of PBS-G, with or without the primary rabbit anti-human complement C3c fragment antibody or anti-human IgG antibody (Sigma, Milano, Italy), at a 1&#x2236;400 dilution, respectively. Complement C3c fragment is the stable derivative of C3b/C3b<sub>2</sub> opsonins <xref ref-type="bibr" rid="pone.0007303-Lutz1">[66]</xref>. Thereafter infected RBCs and non-infected controls were washed twice, suspended in 50 &#xB5;l PBS-G, and incubated for 30 min at room temperature with anti-rabbit IgG-FITC antibody (goat) at 1&#x2236;400. At the end of the incubation, cells were washed twice with 200 &#xB5;l PBS-G, suspended in PBS-G, and analyzed on a BD FACSCalibur Flow Cytometer using Cell Quest software (BD Biosciences). Events were displayed on green fluorescence (FL1) versus forward scatter (FSC) dot plots or FL1 versus events number histogram. RBCs were gated on light scatter characteristics, and a total of at least 30,000 events in gating were collected for each sample. Data analysis was done with WinMDI software.</p>
      </sec>
      <sec id="s4k">
        <title>Phagocytosis of stage-separated infected and control RBCs by THP-1 cells and human mononuclear cells</title>
        <p>The phagocytosis assay was performed utilizing the human monocytic cell line THP-1 or human mononuclear cells.</p>
        <p>1. THP-1 cells were maintained at 0.2&#xD7;10<sup>6</sup> cells/ml in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin, and 100 &#xB5;g/ml streptomycin. The phagocytic ability of THP-1 cells was stimulated by supplementing IFN-gamma (50 U/ml) and TNF (250 U/ml) to the cell suspension 30 h before the start of phagocytosis. Shortly before phagocytosis, cells were washed three times with RPMI 1640 medium and resuspended in Macrophage-SFM medium supplemented with 10% heat-inactivated FBS to obtain 150,000 cells/300 &#xB5;l medium. Ring- or trophozoite-infected and non-infected normal or GR-deficient RBCs were fluorescent-labeled for the phagocytosis assay during 10 min incubation at room temperature with 0.5 &#xB5;M carboxyfluorescein diacetate, succinimidyl ester, (CFDA-SE, Sigma, Milano, Italy) in PBS-G at 0.05% hematocrit. Labeling was stopped by adding 2 ml of heat-inactivated FBS for 5 min. RBCs were then washed three times with PBS-G and co-incubated with THP-1 cells at a THP-1:RBC- ratio of 1&#x2236;100 in round-bottom polypropylene tubes at 37&#xB0;C for 2.5 h (CO<sub>2</sub> 5%). At the end of the incubation, non-ingested RBCs were lysed with 3.5 ml of ice-cold distilled water for 2 min. Physiologic osmolarity was restored by adding 10-times concentrated PBS. Cells were finally washed with cold PBS +1% FBS and analyzed with a BD FACSCalibur Flow Cytometer using Cell Quest software (BD Biosciences). Events were displayed on green fluorescence (FL1) versus forward scatter (FSC) dot plots or FL1 versus events number histogram. THP-1 live cells were gated on light scatter characteristics, and a total of at least 30,000 events in gating were collected for each sample. Data analysis was done with WinMDI software.</p>
        <p>2. Human mononuclear cells were separated by Ficoll separation from buffy coats of healthy donors freshly discarded from the local blood bank, suspended in Macrophage-SFM medium (Invitrogen, Carlsbad, CA), and adhered to 24-well cell culture plates as described <xref ref-type="bibr" rid="pone.0007303-Skorokhod2">[67]</xref>. Phagocytosis was started by the addition of 100 opsonized ring- or trophozoite-infected or non-infected normal or GR-deficient RBCs per monocyte, stopped after 3 h incubation in the CO<sub>2</sub>-incubator, and non-ingested RBCs were removed by lysis and 4 washing steps. Phagocytosis was quantified by measuring the heme-dependent luminol-enhanced luminescence of ingested hemoglobin-heme as described <xref ref-type="bibr" rid="pone.0007303-Schwarzer3">[65]</xref>.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material" id="s5">
      <title>Supporting Information</title>
      <supplementary-material content-type="local-data" id="pone.0007303.s001">
        <label>Figure S1</label>
        <caption>
          <p>Membrane-bound hemichromes, phagocytosis, complement C3c fragment, and autologous IgG in/of GR-deficient and GR-sufficient RBCs - comparison with healthy Italian donors. Data from <xref ref-type="fig" rid="pone-0007303-g001">Figure 1</xref> and <xref ref-type="fig" rid="pone-0007303-g002">Figure 2</xref> of the manuscript were compared to ring-infected and non-infected GR-sufficient control RBCs prepared from 24&#x2013;36 h old blood (kept at +4&#xB0;C) from 7 healthy Italian donors. Mean values of normal controls (mean&#xB1;SD, n&#x200A;=&#x200A;7).</p>
          <p>(1.65 MB TIF)</p>
        </caption>
        <media xlink:href="pone.0007303.s001.tif" mimetype="image" mime-subtype="tiff">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors thank Denisa Baci, Elisabeth Fischer and Marina Fischer for their excellent technical assistance, and Milena Maule for help with the statistics of the Turin data.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pone.0007303-Beutler1">
        <label>1</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Beutler</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <year>2001a</year>
          <article-title>Composition of the erythrocyte.</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname> Beutler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lichtman</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Coller</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Kipps</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Seligsohn</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <source>Williams Hematology, 6th edition</source>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>McGraw-Hill</publisher-name>
          <fpage>289</fpage>
          <lpage>293</lpage>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Beutler2">
        <label>2</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Beutler</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <year>2001b</year>
          <article-title>Energy metabolism and maintenance of erythrocytes.</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Beutler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lichtman</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Coller</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Kipps</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Seligsohn</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <source>Williams Hematology, 6th edition</source>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>McGraw-Hill</publisher-name>
          <fpage>319</fpage>
          <lpage>332</lpage>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Becker1">
        <label>3</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Becker</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rahlfs</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nickel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schirmer</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <year>2003</year>
          <article-title>Glutathione&#x2013;functions and metabolism in the malarial parasite <italic>Plasmodium falciparum</italic>.</article-title>
          <source>Biol Chem</source>
          <volume>384</volume>
          <fpage>551</fpage>
          <lpage>566</lpage>
          <pub-id pub-id-type="pmid">12751785</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Becker2">
        <label>4</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Becker</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tilley</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vennerstrom</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rogerson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ginsburg</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions.</article-title>
          <source>Int J Parasitol</source>
          <volume>34</volume>
          <fpage>163</fpage>
          <lpage>189</lpage>
          <pub-id pub-id-type="pmid">15037104</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Becker3">
        <label>5</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Becker</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Koncarevic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hunt</surname>
              <given-names>NH</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Oxidative stress and antioxidant defense in malarial parasites.</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Sherman</surname>
              <given-names>IW</given-names>
            </name>
          </person-group>
          <source>Molecular Approaches to Malaria</source>
          <publisher-loc>Herndon</publisher-loc>
          <publisher-name>American Society of Microbiology Press</publisher-name>
          <fpage>365</fpage>
          <lpage>383</lpage>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Atamna1">
        <label>6</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Atamna</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ginsburg</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <year>1995</year>
          <article-title>Heme degradation in the presence of glutathione. A proposed mechanism to account for the high levels of non-heme iron found in the membranes of hemoglobinopathic red blood cells.</article-title>
          <source>J Biol Chem</source>
          <volume>270</volume>
          <fpage>24876</fpage>
          <lpage>24883</lpage>
          <pub-id pub-id-type="pmid">7559611</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Akoachere1">
        <label>7</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akoachere</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Iozef</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rahlfs</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Deponte</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mannervik</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2005</year>
          <article-title>Characterization of the glyoxalases of the malarial parasite <italic>Plasmodium falciparum</italic> and comparison with their human counterparts.</article-title>
          <source>Biol Chem</source>
          <volume>386</volume>
          <fpage>41</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">15843146</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Hiller1">
        <label>8</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hiller</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fritz-Wolf</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Deponte</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wende</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zimmermann</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2006</year>
          <article-title><italic>Plasmodium falciparum</italic> glutathione S-transferase&#x2013;structural and mechanistic studies on ligand binding and enzyme inhibition.</article-title>
          <source>Protein Sci</source>
          <volume>15</volume>
          <fpage>281</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="pmid">16385005</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-KrauthSiegel1">
        <label>9</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krauth-Siegel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schirmer</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia.</article-title>
          <source>Angew Chem Int Ed Engl</source>
          <volume>44</volume>
          <fpage>690</fpage>
          <lpage>715</lpage>
          <pub-id pub-id-type="pmid">15657967</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Buchholz1">
        <label>10</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buchholz</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mwongela Mailu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Heiner Schirmer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <year>2007</year>
          <article-title>Structure-Based Drug Development Against Malaria.</article-title>
          <source>Frontiers in Drug Design &amp; Discovery</source>
          <volume>3</volume>
          <fpage>225</fpage>
          <lpage>255</lpage>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Rahlfs1">
        <label>11</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rahlfs</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <year>2006</year>
          <article-title>Interference with redox-active enzymes as a basis for the design of antimalarial drugs.</article-title>
          <source>Mini Rev Med Chem</source>
          <volume>6</volume>
          <fpage>163</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="pmid">16472185</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Beutler3">
        <label>12</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Beutler</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <year>2001c</year>
          <article-title>Glucose-6-phosphate dehydrogenase deficiency and other red cell enzyme abnormalities.</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Beutler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lichtman</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Coller</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Kipps</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Seligsohn</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <source>Williams Hematology, 6th edition</source>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>McGraw-Hill</publisher-name>
          <fpage>527</fpage>
          <lpage>545</lpage>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Luzzatto1">
        <label>13</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Luzzatto</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vulliamy</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <year>2001</year>
          <article-title>Glucose-6-phosphate dehydrogenase deficiency.</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Scriver</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Beaudet</surname>
              <given-names>RAL</given-names>
            </name>
            <name>
              <surname>Sly</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Vallet</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <source>The Metabolic and Molecular Bases of Inherited Disease</source>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>McGraw-Hill</publisher-name>
          <fpage>4517</fpage>
          <lpage>4553</lpage>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Greene1">
        <label>14</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greene</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <year>1993</year>
          <article-title>G6PD deficiency as protection against <italic>falciparum</italic> malaria: an epidemiologic critique of population and experimental studies.</article-title>
          <source>Yearb Phys Anthropol</source>
          <volume>36</volume>
          <fpage>26</fpage>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Nkhoma1">
        <label>15</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nkhoma</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Poole</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vannappagari</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Beutler</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <year>2009</year>
          <article-title>The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.</article-title>
          <source>Blood Cells Mol Dis</source>
          <comment>pub ahead of print, Feb. 2009</comment>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Beutler4">
        <label>16</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beutler</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <year>1996</year>
          <article-title>G6PD: population genetics and clinical manifestations.</article-title>
          <source>Blood Rev</source>
          <volume>10</volume>
          <fpage>45</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">8861278</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Loos1">
        <label>17</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loos</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Roos</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Weening</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Houwerzijl</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <year>1976</year>
          <article-title>Familial deficiency of glutathione reductase in human blood cells.</article-title>
          <source>Blood</source>
          <volume>48</volume>
          <fpage>53</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">947404</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Kamerbeek1">
        <label>18</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kamerbeek</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>van Zwieten</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>de Boer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morren</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vuil</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2007</year>
          <article-title>Molecular basis of glutathione reductase deficiency in human blood cells.</article-title>
          <source>Blood</source>
          <volume>109</volume>
          <fpage>3560</fpage>
          <lpage>3566</lpage>
          <pub-id pub-id-type="pmid">17185460</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Ruwende1">
        <label>19</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruwende</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <year>1998</year>
          <article-title>Glucose-6-phosphate dehydrogenase deficiency and malaria.</article-title>
          <source>J Mol Med</source>
          <volume>76</volume>
          <fpage>581</fpage>
          <lpage>588</lpage>
          <pub-id pub-id-type="pmid">9694435</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Cappadoro1">
        <label>20</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cappadoro</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Giribaldi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Turrini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mannu</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1998</year>
          <article-title>Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by <italic>Plasmodium falciparum</italic> may explain malaria protection in G6PD deficiency.</article-title>
          <source>Blood</source>
          <volume>92</volume>
          <fpage>2527</fpage>
          <lpage>2534</lpage>
          <pub-id pub-id-type="pmid">9746794</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Arese1">
        <label>21</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arese</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Turrini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Schwarzer</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes.</article-title>
          <source>Cell Physiol Biochem</source>
          <volume>16</volume>
          <fpage>133</fpage>
          <lpage>146</lpage>
          <pub-id pub-id-type="pmid">16301814</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Ayi1">
        <label>22</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ayi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Turrini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Piga</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Arese</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait.</article-title>
          <source>Blood</source>
          <volume>104</volume>
          <fpage>3364</fpage>
          <lpage>3371</lpage>
          <pub-id pub-id-type="pmid">15280204</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Ayi2">
        <label>23</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ayi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Min-Oo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Serghides</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Crockett</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kirby-Allen</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2008</year>
          <article-title>Pyruvate kinase deficiency and malaria.</article-title>
          <source>N Engl J Med</source>
          <volume>358</volume>
          <fpage>1805</fpage>
          <lpage>1810</lpage>
          <pub-id pub-id-type="pmid">18420493</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Williams1">
        <label>24</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <year>2006</year>
          <article-title>Human red blood cell polymorphisms and malaria.</article-title>
          <source>Curr Opin Microbiol</source>
          <volume>9</volume>
          <fpage>388</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="pmid">16815736</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Roberts1">
        <label>25</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>The influence of inherited traits on malaria infection.</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Bellamy</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <source>Susceptibility to Infectious Diseases: the Importance of Host Genetics</source>
          <publisher-loc>Cambridge</publisher-loc>
          <publisher-name>Cambridge University Press</publisher-name>
          <fpage>139</fpage>
          <lpage>184</lpage>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-MinOo1">
        <label>26</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Min-Oo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gros</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Erythrocyte variants and the nature of their malaria protective effect.</article-title>
          <source>Cell Microbiol</source>
          <volume>7</volume>
          <fpage>753</fpage>
          <lpage>763</lpage>
          <pub-id pub-id-type="pmid">15888079</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Arie1">
        <label>27</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arie</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fairhurst</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brittain</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wellems</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dvorak</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Hemoglobin C modulates the surface topography of <italic>Plasmodium falciparum</italic>-infected erythrocytes.</article-title>
          <source>J Struct Biol</source>
          <volume>150</volume>
          <fpage>163</fpage>
          <lpage>169</lpage>
          <pub-id pub-id-type="pmid">15866739</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Tokumasu1">
        <label>28</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tokumasu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fairhurst</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ostera</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Brittain</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2005</year>
          <article-title>Band 3 modifications in <italic>Plasmodium falciparum</italic>-infected AA and CC erythrocytes assayed by autocorrelation analysis using quantum dots.</article-title>
          <source>J Cell Sci</source>
          <volume>118</volume>
          <fpage>1091</fpage>
          <lpage>1098</lpage>
          <pub-id pub-id-type="pmid">15731014</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Chotivanich1">
        <label>29</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chotivanich</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Udomsangpetch</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pattanapanyasat</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chierakul</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2002</year>
          <article-title>Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe <italic>P. falciparum</italic> malaria.</article-title>
          <source>Blood</source>
          <volume>100</volume>
          <fpage>1172</fpage>
          <lpage>1176</lpage>
          <pub-id pub-id-type="pmid">12149194</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Turrini1">
        <label>30</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turrini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ginsburg</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bussolino</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pescarmona</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Serra</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Arese</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <year>1992</year>
          <article-title>Phagocytosis of <italic>Plasmodium falciparum</italic>-infected human red blood cells by human monocytes: involvement of immune and nonimmune determinants and dependence on parasite developmental stage.</article-title>
          <source>Blood</source>
          <volume>80</volume>
          <fpage>801</fpage>
          <lpage>808)</lpage>
          <pub-id pub-id-type="pmid">1638029</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Schwarzer1">
        <label>31</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwarzer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Turrini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ulliers</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Giribaldi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ginsburg</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1992</year>
          <article-title>Impairment of macrophage functions after ingestion of <italic>Plasmodium falciparum</italic>-infected erythrocytes or isolated malarial pigment.</article-title>
          <source>J Exp Med</source>
          <volume>176</volume>
          <fpage>1033</fpage>
          <lpage>1041</lpage>
          <pub-id pub-id-type="pmid">1402649</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Hnscheid1">
        <label>32</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>H&#xE4;nscheid</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Egan</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Grobusch</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <year>2007</year>
          <article-title>Haemozoin: from melatonin pigment to drug target, diagnostic tool, and immune modulator.</article-title>
          <source>Lancet Infect Dis</source>
          <volume>7</volume>
          <fpage>675</fpage>
          <lpage>685</lpage>
          <pub-id pub-id-type="pmid">17897610</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Fiori1">
        <label>33</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fiori</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rappelli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mirkarimi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ginsburg</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cappuccinelli</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1993</year>
          <article-title>Reduced microbicidal and anti-tumour activities of human monocytes after ingestion of <italic>Plasmodium falciparum</italic>-infected red blood cells.</article-title>
          <source>Parasite Immunol</source>
          <volume>15</volume>
          <fpage>647</fpage>
          <lpage>655</lpage>
          <pub-id pub-id-type="pmid">7877842</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Schwarzer2">
        <label>34</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwarzer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Alessio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ulliers</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Arese</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <year>1998</year>
          <article-title>Phagocytosis of the malarial pigment, hemozoin, impairs expression of major histocompatibility complex class II antigen, CD54, and CD11c in human monocytes.</article-title>
          <source>Infect Immun</source>
          <volume>66</volume>
          <fpage>1601</fpage>
          <lpage>1606</lpage>
          <pub-id pub-id-type="pmid">9529087</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Scorza1">
        <label>35</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scorza</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Magez</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Brys</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>De Baetselier</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <year>1999</year>
          <article-title>Hemozoin is a key factor in the induction of malaria-associated immunosuppression.</article-title>
          <source>Parasite Immunol</source>
          <volume>21</volume>
          <fpage>545</fpage>
          <lpage>554</lpage>
          <pub-id pub-id-type="pmid">10583855</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Skorokhod1">
        <label>36</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skorokhod</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Alessio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mordm&#xFC;ller</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Arese</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schwarzer</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-gamma-mediated effect.</article-title>
          <source>J Immunol</source>
          <volume>173</volume>
          <fpage>4066</fpage>
          <lpage>4074</lpage>
          <pub-id pub-id-type="pmid">15356156</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Chakravorty1">
        <label>37</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chakravorty</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Craig</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <year>2008</year>
          <article-title>Host response to cytoadherence in <italic>Plasmodium falciparum</italic>.</article-title>
          <source>Biochem Soc Trans</source>
          <volume>36</volume>
          <fpage>221</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">18363564</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Cholera1">
        <label>38</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cholera</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brittain</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gillrie</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lopera-Mesa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Diakit&#xE9;</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2008</year>
          <article-title>Impaired cytoadherence of <italic>Plasmodium falciparum</italic>-infected erythrocytes containing sickle hemoglobin.</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <volume>105</volume>
          <fpage>991</fpage>
          <lpage>996</lpage>
          <pub-id pub-id-type="pmid">18192399</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Fairhurst1">
        <label>39</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fairhurst</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wellems</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <year>2006</year>
          <article-title>Modulation of malaria virulence by determinants of <italic>Plasmodium falciparum</italic> erythrocyte membrane protein-1 display.</article-title>
          <source>Curr Opin Hematol</source>
          <volume>13</volume>
          <fpage>124</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">16567953</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Fairhurst2">
        <label>40</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fairhurst</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Baruch</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Brittain</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ostera</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wallach</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <year>2005</year>
          <article-title>Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria.</article-title>
          <source>Nature</source>
          <volume>435</volume>
          <fpage>1117</fpage>
          <lpage>1121</lpage>
          <pub-id pub-id-type="pmid">15973412</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Arese2">
        <label>41</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arese</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>De Flora</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <year>1990</year>
          <article-title>Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency.</article-title>
          <source>Semin Hematol</source>
          <volume>27</volume>
          <fpage>1</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">2405494</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-KomakiYasuda1">
        <label>42</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Komaki-Yasuda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kawazu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kano</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <year>2003</year>
          <article-title>Disruption of the <italic>Plasmodium falciparum</italic> 2-Cys peroxiredoxin gene renders parasites hypersensitive to reactive oxygen and nitrogen species.</article-title>
          <source>FEBS Lett</source>
          <volume>547</volume>
          <fpage>140</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="pmid">12860402</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Schulz1">
        <label>43</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schulz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Schirmer</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Pai</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <year>1982</year>
          <article-title>FAD-binding site of glutathione reductase.</article-title>
          <source>J Mol Biol</source>
          <volume>160</volume>
          <fpage>287</fpage>
          <lpage>308</lpage>
          <pub-id pub-id-type="pmid">7175934</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Ahmed1">
        <label>44</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahmed</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Banu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Qazi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Akhtaruzzaman</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <year>2008</year>
          <article-title>The coexistence of other micronutrient deficiencies in anaemic adolescent schoolgirls in rural Bangladesh.</article-title>
          <source>Eur J Clin Nutr</source>
          <volume>62</volume>
          <fpage>365</fpage>
          <lpage>372</lpage>
          <pub-id pub-id-type="pmid">17327866</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Rohner1">
        <label>45</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rohner</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zimmermann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wegmueller</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tschannen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hurrell</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <year>2007</year>
          <article-title>Mild riboflavin deficiency is highly prevalent in school-age children but does not increase risk for anaemia in C&#xF4;te d'Ivoire.</article-title>
          <source>Br J Nutr</source>
          <volume>97</volume>
          <fpage>970</fpage>
          <lpage>976</lpage>
          <pub-id pub-id-type="pmid">17381972</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Das1">
        <label>46</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Das</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Satpathy</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Patnaik</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bose</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <year>1988</year>
          <article-title>Riboflavin deficiency and severity of malaria.</article-title>
          <source>Eur J Clin Nutr</source>
          <volume>42</volume>
          <fpage>277</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="pmid">3293996</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Kaikai1">
        <label>47</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaikai</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Thurnham</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <year>1983</year>
          <article-title>The influence of riboflavin deficiency on <italic>Plasmodium berghei</italic> infection in rats.</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <volume>77</volume>
          <fpage>680</fpage>
          <lpage>686</lpage>
          <pub-id pub-id-type="pmid">6362121</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Anderson1">
        <label>48</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Giubert</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Salsini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Casadio</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1993</year>
          <article-title>Low red blood cell glutathione reductase and pyridoxine phosphate oxidase activities not related to dietary riboflavin: selection by malaria?</article-title>
          <source>Am J Clin Nutr</source>
          <volume>57</volume>
          <fpage>666</fpage>
          <lpage>672</lpage>
          <pub-id pub-id-type="pmid">8480684</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Anderson2">
        <label>49</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Scattoni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Galvan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Giuberti</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1994</year>
          <article-title>Is the flavin-deficient red blood cell common in Maremma, Italy, an important defense against malaria in this area?</article-title>
          <source>Am J Hum Genet</source>
          <volume>55</volume>
          <fpage>975</fpage>
          <lpage>980</lpage>
          <pub-id pub-id-type="pmid">7977361</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Anderson3">
        <label>50</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Corda</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pilato</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Giuberti</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1995</year>
          <article-title>Deficiency of two red-cell flavin enzymes in a population in Sardinia: was glutathione reductase deficiency specifically selected for by malaria?</article-title>
          <source>Am J Hum Genet</source>
          <volume>57</volume>
          <fpage>674</fpage>
          <lpage>681</lpage>
          <pub-id pub-id-type="pmid">7668297</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Siniscalco1">
        <label>51</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siniscalco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bernini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Filippi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Latte</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Meera-Khan</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1966</year>
          <article-title>Population genetics of haemoglobin variants, thalassaemia and glucose-6-phosphate dehydrogenase deficiency, with particular reference to the malaria hypothesis.</article-title>
          <source>Bull World Health Organ</source>
          <volume>34</volume>
          <fpage>379</fpage>
          <lpage>393</lpage>
          <pub-id pub-id-type="pmid">5296398</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-ElHazmi1">
        <label>52</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Hazmi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Warsy</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <year>1985</year>
          <article-title>Glutathione reductase deficiency in association with sickle cell and thalassaemia genes in Saudi populations.</article-title>
          <source>Hum Hered</source>
          <volume>35</volume>
          <fpage>326</fpage>
          <lpage>332</lpage>
          <pub-id pub-id-type="pmid">4043983</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Anderson4">
        <label>53</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Clements</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Studds</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fashola</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <year>1989</year>
          <article-title>Genetic and other influences on red-cell flavin enzymes, pyridoxine phosphate oxidase and glutathione reductase in families with beta-thalassaemia.</article-title>
          <source>Eur J Haematol</source>
          <volume>42</volume>
          <fpage>354</fpage>
          <lpage>360</lpage>
          <pub-id pub-id-type="pmid">2721660</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Clements1">
        <label>54</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clements</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <year>1981</year>
          <article-title>Low red cell activity of pyridoxine (pyridoxamine) phosphate oxidase and glutathione reductase associated with thalassaemia.</article-title>
          <source>Biomedicine</source>
          <volume>34</volume>
          <fpage>119</fpage>
          <lpage>123</lpage>
          <pub-id pub-id-type="pmid">7337797</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Varma1">
        <label>55</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Varma</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mankad</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Phelps</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Suskind</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <year>1983</year>
          <article-title>Depressed erythrocyte glutathione reductase activity in sickle cell disease.</article-title>
          <source>Am J Clin Nutr</source>
          <volume>38</volume>
          <fpage>884</fpage>
          <lpage>887</lpage>
          <pub-id pub-id-type="pmid">6650447</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Zhang1">
        <label>56</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>YA</given-names>
            </name>
            <name>
              <surname>K&#xF6;nig</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Schirmer</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <year>1988</year>
          <article-title>Glutathione reductase-deficient erythrocytes as host cells of malarial parasites.</article-title>
          <source>Biochem Pharmacol</source>
          <volume>37</volume>
          <fpage>861</fpage>
          <lpage>865</lpage>
          <pub-id pub-id-type="pmid">3278713</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Frischer1">
        <label>57</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frischer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ahmad</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <year>1977</year>
          <article-title>Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU [1,3-bis(chloroethyl)-1-nitrosourea].</article-title>
          <source>J Lab Clin Med</source>
          <volume>89</volume>
          <fpage>1080</fpage>
          <lpage>1091</lpage>
          <pub-id pub-id-type="pmid">870569</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Trager1">
        <label>58</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trager</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <year>1976</year>
          <article-title>Human malaria parasites in continuous culture.</article-title>
          <source>Science</source>
          <volume>193</volume>
          <fpage>673</fpage>
          <lpage>675</lpage>
          <pub-id pub-id-type="pmid">781840</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Lambros1">
        <label>59</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lambros</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vanderberg</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <year>1979</year>
          <article-title>Synchronization of <italic>Plasmodium falciparum</italic> erythrocytic stages in culture.</article-title>
          <source>J Parasitol</source>
          <volume>65</volume>
          <fpage>418</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="pmid">383936</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Becker4">
        <label>60</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Becker</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gui</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Traxler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kirsten</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schirmer</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <year>1994</year>
          <article-title>Redox processes in malaria and other parasitic diseases. Determination of intracellular glutathione.</article-title>
          <source>Histochemistry</source>
          <volume>102</volume>
          <fpage>389</fpage>
          <lpage>395</lpage>
          <pub-id pub-id-type="pmid">7868369</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Nordhoff1">
        <label>61</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nordhoff</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>B&#xFC;cheler</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Schirmer</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <year>1993</year>
          <article-title>Folding of the four domains and dimerization are impaired by the Gly446&#x2013;&gt;Glu exchange in human glutathione reductase. Implications for the design of antiparasitic drugs.</article-title>
          <source>Biochemistry</source>
          <volume>32</volume>
          <fpage>4060</fpage>
          <lpage>4066</lpage>
          <pub-id pub-id-type="pmid">8097111</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Desjardins1">
        <label>62</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Desjardins</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Canfield</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Haynes</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chulay</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <year>1979</year>
          <article-title>Quantitative assessment of antimalarial activity <italic>in vitro</italic> by a semiautomated microdilution technique.</article-title>
          <source>Antimicrob Agents Chemother</source>
          <volume>16</volume>
          <fpage>710</fpage>
          <lpage>718</lpage>
          <pub-id pub-id-type="pmid">394674</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Fivelman1">
        <label>63</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fivelman</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Adagu</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Warhurst</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of <italic>Plasmodium falciparum</italic>.</article-title>
          <source>Antimicrob Agents Chemother</source>
          <volume>48</volume>
          <fpage>4097</fpage>
          <lpage>4102</lpage>
          <pub-id pub-id-type="pmid">15504827</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Steck1">
        <label>64</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steck</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Weinstein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Straus</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wallach</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <year>1970</year>
          <article-title>Inside-out red cell membrane vesicles: preparation and purification.</article-title>
          <source>Science</source>
          <volume>168</volume>
          <fpage>255</fpage>
          <lpage>257</lpage>
          <pub-id pub-id-type="pmid">5418644</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Schwarzer3">
        <label>65</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwarzer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Turrini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Arese</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <year>1994</year>
          <article-title>A luminescence method for the quantitative determination of phagocytosis of erythrocytes, of malaria-parasitized erythrocytes and of malarial pigment.</article-title>
          <source>Br J Haematol</source>
          <volume>88</volume>
          <fpage>740</fpage>
          <lpage>745</lpage>
          <pub-id pub-id-type="pmid">7819098</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Lutz1">
        <label>66</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lutz</surname>
              <given-names>HU</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Innate immune and non-immune mediators of erythrocyte clearance.</article-title>
          <source>Cell Mol Biol</source>
          <volume>50</volume>
          <fpage>107</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="pmid">15095782</pub-id>
        </mixed-citation>
      </ref>
      <ref id="pone.0007303-Skorokhod2">
        <label>67</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skorokhod</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Schwarzer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ceretto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Arese</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <year>2007</year>
          <article-title>Malarial pigment haemozoin, IFN-gamma, TNF-alpha, IL-1beta and LPS do not stimulate expression of inducible nitric oxide synthase and production of nitric oxide in immuno-purified human monocytes.</article-title>
          <source>Malar J</source>
          <volume>6</volume>
          <fpage>73</fpage>
          <pub-id pub-id-type="pmid">17543124</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p><bold>Funding: </bold>The study was supported by the German Research Council (BE1540/15-1 to KB and SFB 544 TP B2 to RHS). PA and ES were supported by grants from Compagnia di San Paolo in the context of the Italian Malaria Network, from Regione Piemonte (Progetti di Ricerca Sanitaria Finalizzata), and from the University of Turin Medical School Intramural Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
      </fn>
    </fn-group>
  </back>
</article>
</pmc-articleset>
